An observational study to determine best practice based on clinicians’ reported management of NSW melanoma patients over a 12-month period.
Searching for early-detection genetic markers and treatment options for 20 to 39 year olds.
Cited an incredible 427 times around the world, showing its vital role in improving outcomes for people with advanced melanoma.
The 'Distinguished Alumni Award' from University of Tasmania honours the exceptional impact of his work around the world.
The 'Outstanding Research Award' recognises their life-saving discoveries transforming melanoma patient care.
National day of action called amidst fears COVID lockdowns have deterred patients from seeking potentially life-saving medical treatment.